APPLICATION
ANDA201000
TYPE
ANDA
ORIGINAL APPROVAL
2014-10-27
LATEST ACTION
2024-08-26
ROUTE
TOPICAL
DOSAGE FORM
GEL
MARKETING STATUS
Prescription
Products
ADAPALENEPrescription
ADAPALENE 0.3% · GEL · TOPICAL
Approval history
2024-08-26Labeling · Supplement 7 · standardAP
2023-04-11Labeling · Supplement 6 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.